Trial # D3250C00024: A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy & Safety study of Benralizumab in Pediatric Patients with Severe Eosinophilic Asthma (DOMINICA)